The insulin-like growth factor (IGF) pathway is implicated in the pathogenesis of hepatocellular carcinoma (HCC) and may be important in nonalcoholic fatty liver disease (NAFLD). The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.